[ad_1]
ASHGABAT, Turkmenistan, July 8.
Kazakhstan’s Institute of Nuclear Physics under the Ministry of
Energy and Swiss Ostro Minerals company signed agreements on
investing in what the institute was working on, Trend reports.
The documents were signed during the meeting held
between the country’s Energy Minister Almassadam Satkaliyev and
President of the Ostro Minerals company Maurice Samuel Ostro.
At the meeting, Ostro Minerals expressed interest in
the products of the Institute of Nuclear Physics. In particular,
the company was interested in industrial and medical radioactive
isotopes (radiopharmaceuticals) produced by the institute.
Meanwhile, the Institute of Nuclear Physics produces
radiopharmaceuticals for the diagnosis and treatment of oncological
diseases, as well as industrial radioisotopes. The institute
accounts for 90 percent of all radiopharmaceuticals produced in
Kazakhstan and supplied to medical institutions across the
country.
Previously, the Ministry of Energy of Kazakhstan held
several negotiations to attract investment in the Institute of
Nuclear Physics for expanding the range of industrial and medical
radioisotopes produced by the institute and increasing exports to
European countries.
In 2022, the institute successfully made its first
product delivery to Germany.
[ad_2]
Source link
